Gelteq (GELS) Cash & Current Investments (2023 - 2025)
Gelteq's (GELS) quarterly Cash & Current Investments came in at $48561.6 in Q4 2025, down 97.56% year-on-year from $2.0 million in Q4 2024, and down 93.21% quarter-over-quarter from $714808.0 in Q2 2025.
Gelteq (GELS) Cash & Current Investments (2023 - 2025) Analysis & Trends
Gelteq's Cash & Current Investments history runs 3 years deep, the most recent figure standing at $48561.6 for Q4 2025.
- On a quarterly basis, Cash & Current Investments fell 97.56% year-over-year to $48561.6 in Q4 2025; TTM through Dec 2025 was $48561.6, a 97.56% decrease from a year earlier, with the FY2025 full-year figure at $714808.0, up 4323.15% from the prior year.
- Cash & Current Investments fell to $48561.6 in Q4 2025 per GELS's latest filing, from $714808.0 in the prior quarter.
- Across five years, Cash & Current Investments topped out at $2.0 million in Q4 2024 and bottomed at $16160.6 in Q2 2024.
- The 3-year median for Cash & Current Investments is $266825.5 (2023), against an average of $607740.2.
- Biggest YoY gain for Cash & Current Investments was 4323.15% in 2025; the steepest drop was 97.56% in 2025.
- Year by year, Cash & Current Investments stood at $266825.5 in 2023, then surged by 646.68% to $2.0 million in 2024, then tumbled by 97.56% to $48561.6 in 2025.
- Per Business Quant, the three latest GELS Cash & Current Investments figures stand at $48561.6 (Q4 2025), $714808.0 (Q2 2025), and $2.0 million (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.95 Bn | 88.09 Bn | - | 1.86 Bn |
| 2 | Teva Pharmaceutical Industries | 35.95 Bn | 32.20 Bn | 1.97 Bn | 3.74 Bn |
| 3 | Zoetis | 32.60 Bn | 30.66 Bn | 1.62 Bn | 1.94 Bn |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn | 4.06 Bn |
| 5 | United Therapeutics | 23.07 Bn | 20.91 Bn | 648.10 Mn | 2.15 Bn |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.35 Bn | 18.55 Bn | 1.16 Bn | 1.80 Bn |
| 8 | Neurocrine Biosciences | 17.78 Bn | 16.47 Bn | 800.70 Mn | 1.32 Bn |
| 9 | Elanco Animal Health | 12.63 Bn | 12.20 Bn | 785.00 Mn | 428.00 Mn |
| 10 | Gelteq | 670.00 | -47,891.64 | - | 48,561.64 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 48,561.64 |
| Jun 30, 2025 | 714,807.99 |
| Dec 31, 2024 | 1.99 Mn |
| Jun 30, 2024 | 16,160.60 |
| Jun 30, 2023 | 266,825.53 |